These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
238 related articles for article (PubMed ID: 26666824)
1. Up-regulation of SRPK1 in non-small cell lung cancer promotes the growth and migration of cancer cells. Liu H; Hu X; Zhu Y; Jiang G; Chen S Tumour Biol; 2016 Jun; 37(6):7287-93. PubMed ID: 26666824 [TBL] [Abstract][Full Text] [Related]
2. Chimeric antibody targeting SRPK-1 in the treatment of non-small cell lung cancer by inhibiting growth, migration and invasion. Wu F; Li J; Du X; Zhang W; Lei P; Zhang Q Mol Med Rep; 2017 Aug; 16(2):2121-2127. PubMed ID: 28656224 [TBL] [Abstract][Full Text] [Related]
3. Serum and glucocorticoid kinase 1 promoted the growth and migration of non-small cell lung cancer cells. Xiaobo Y; Qiang L; Xiong Q; Zheng R; Jianhua Z; Zhifeng L; Yijiang S; Zheng J Gene; 2016 Jan; 576(1 Pt 2):339-46. PubMed ID: 26548813 [TBL] [Abstract][Full Text] [Related]
4. Serine-arginine protein kinase 1 promotes a cancer stem cell-like phenotype through activation of Wnt/β-catenin signalling in NSCLC. Gong L; Song J; Lin X; Wei F; Zhang C; Wang Z; Zhu J; Wu S; Chen Y; Liang J; Fu X; Lu J; Zhou C; Song L J Pathol; 2016 Oct; 240(2):184-96. PubMed ID: 27391422 [TBL] [Abstract][Full Text] [Related]
5. HEPACAM inhibited the growth and migration of cancer cells in the progression of non-small cell lung cancer. Shao H; Gu Y; Ding J; Lu P; Ruan T; Lu W Tumour Biol; 2016 Feb; 37(2):2621-7. PubMed ID: 26392113 [TBL] [Abstract][Full Text] [Related]
6. DDX5 promotes proliferation and tumorigenesis of non-small-cell lung cancer cells by activating β-catenin signaling pathway. Wang Z; Luo Z; Zhou L; Li X; Jiang T; Fu E Cancer Sci; 2015 Oct; 106(10):1303-12. PubMed ID: 26212035 [TBL] [Abstract][Full Text] [Related]
7. Down-regulation of LATS2 in non-small cell lung cancer promoted the growth and motility of cancer cells. Yao F; Liu H; Li Z; Zhong C; Fang W Tumour Biol; 2015 Mar; 36(3):2049-57. PubMed ID: 25391426 [TBL] [Abstract][Full Text] [Related]
8. Serine-arginine protein kinase 1 (SRPK1) promotes EGFR-TKI resistance by enhancing GSK3β Ser9 autophosphorylation independent of its kinase activity in non-small-cell lung cancer. Huang JQ; Duan LX; Liu QY; Li HF; Hu AP; Song JW; Lin C; Huang B; Yao D; Peng B; Sun Y; Wen Y; Yang L; Xu X; Gong LY Oncogene; 2023 Apr; 42(15):1233-1246. PubMed ID: 36869126 [TBL] [Abstract][Full Text] [Related]
9. KDM2A promotes lung tumorigenesis by epigenetically enhancing ERK1/2 signaling. Wagner KW; Alam H; Dhar SS; Giri U; Li N; Wei Y; Giri D; Cascone T; Kim JH; Ye Y; Multani AS; Chan CH; Erez B; Saigal B; Chung J; Lin HK; Wu X; Hung MC; Heymach JV; Lee MG J Clin Invest; 2013 Dec; 123(12):5231-46. PubMed ID: 24200691 [TBL] [Abstract][Full Text] [Related]
10. Role of high expression levels of STK39 in the growth, migration and invasion of non-small cell type lung cancer cells. Li Z; Zhu W; Xiong L; Yu X; Chen X; Lin Q Oncotarget; 2016 Sep; 7(38):61366-61377. PubMed ID: 27542260 [TBL] [Abstract][Full Text] [Related]
11. YEATS4 promotes the tumorigenesis of pancreatic cancer by activating beta-catenin/TCF signaling. Jixiang C; Shengchun D; Jianguo Q; Zhengfa M; Xin F; Xuqing W; Jianxin Z; Lei C Oncotarget; 2017 Apr; 8(15):25200-25210. PubMed ID: 28445953 [TBL] [Abstract][Full Text] [Related]
12. Upregulation of mediator MED23 in non-small-cell lung cancer promotes the growth, migration, and metastasis of cancer cells. Shi J; Liu H; Yao F; Zhong C; Zhao H Tumour Biol; 2014 Dec; 35(12):12005-13. PubMed ID: 25273169 [TBL] [Abstract][Full Text] [Related]
13. TGIF1 promoted the growth and migration of cancer cells in nonsmall cell lung cancer. Xiang G; Yi Y; Weiwei H; Weiming W Tumour Biol; 2015 Dec; 36(12):9303-10. PubMed ID: 26104768 [TBL] [Abstract][Full Text] [Related]
14. HDAC2 promotes the migration and invasion of non-small cell lung cancer cells via upregulation of fibronectin. Li L; Mei DT; Zeng Y Biomed Pharmacother; 2016 Dec; 84():284-290. PubMed ID: 27665474 [TBL] [Abstract][Full Text] [Related]
15. MiR-410 induces stemness by inhibiting Gsk3β but upregulating β-catenin in non-small cells lung cancer. Ke X; Yuan Y; Guo C; Yang Y; Pu Q; Hu X; Tang K; Luo X; Jiang Q; Su X; Liu L; Zhu W; Wei Y Oncotarget; 2017 Feb; 8(7):11356-11371. PubMed ID: 28076327 [TBL] [Abstract][Full Text] [Related]
16. Transcriptional regulation of livin by beta-catenin/TCF signaling in human lung cancer cell lines. Yuan D; Liu L; Gu D Mol Cell Biochem; 2007 Dec; 306(1-2):171-8. PubMed ID: 17660948 [TBL] [Abstract][Full Text] [Related]
17. Paired box 5 is a frequently methylated lung cancer tumour suppressor gene interfering β-catenin signalling and GADD45G expression. Zhao L; Li S; Gan L; Li C; Qiu Z; Feng Y; Li J; Li L; Li C; Peng W; Xu C; Wang Z; Hui T; Ren G; Tao Q; Xiang T J Cell Mol Med; 2016 May; 20(5):842-54. PubMed ID: 26843424 [TBL] [Abstract][Full Text] [Related]
18. DKK1 promotes migration and invasion of non-small cell lung cancer via β-catenin signaling pathway. Zhang J; Zhang X; Zhao X; Jiang M; Gu M; Wang Z; Yue W Tumour Biol; 2017 Jul; 39(7):1010428317703820. PubMed ID: 28677426 [TBL] [Abstract][Full Text] [Related]
19. Repression of TIF1γ by SOX2 promotes TGF-β-induced epithelial-mesenchymal transition in non-small-cell lung cancer. Wang L; Yang H; Lei Z; Zhao J; Chen Y; Chen P; Li C; Zeng Y; Liu Z; Liu X; Zhang HT Oncogene; 2016 Feb; 35(7):867-77. PubMed ID: 25961934 [TBL] [Abstract][Full Text] [Related]
20. Mutant KRAS associated malic enzyme 1 expression is a predictive marker for radiation therapy response in non-small cell lung cancer. Chakrabarti G Radiat Oncol; 2015 Jul; 10():145. PubMed ID: 26173780 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]